Oruka Therapeutics Inc. Common Stock vs Stellantis N.V. Common Shares — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Stellantis N.V. Common Shares trades at $4.28 (market cap $16.51B). The key difference: Stellantis N.V. Common Shares is far larger — about 3.2× Oruka Therapeutics Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Stellantis N.V. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Stellantis N.V. Common Shares for 0 Days on average.
| ORKA | STLA | |
|---|---|---|
Market Cap | $5.18B | $16.51B |
Volume | 490,798 | 28,274,156 |
Sector | Health | Consumer Cyclical |
52-Week High | $113.08 | $12.12 |
52-Week Low | $26.19 | $4.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.31B | $36.19B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →Stellantis N.V. is a multinational automaker formed from the 2021 merger of Fiat Chrysler Automobiles and PSA Group, manufacturing vehicles under brands including Jeep, Ram, Chrysler, Dodge, Fiat, Peugeot, and Citroën.
Read more on STLA →